Ignite Creation Date:
2024-05-05 @ 10:18 PM
Last Modification Date:
2024-10-26 @ 10:16 AM
Study NCT ID:
NCT01076023
Status:
UNKNOWN
Last Update Posted:
2013-02-15
First Post:
2010-02-24
Brief Title:
Cohort Study in Type 2 Diabetes in China
Sponsor:
China Cardiometabolic Registries
Organization:
China Cardiometabolic Registries
Study Overview
Official Title:
Comprehensive Cohort Study in Type 2 Diabetes With High Risk of Cardiovascular Disease in China
Status:
UNKNOWN
Status Verified Date:
2010-02
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CCDC
Brief Summary:
This study is designed to assess the incidence of cardiovascular events occurred within an 12 month follow up period in type 2 diabetic patients with either high risk of cardiovascular disease CVD or history of coronary artery disease CAD or stroke
Detailed Description:
The number of diabetes patients around the world has increased from 30 million in 1985 to the current 180 million and is expected to grow to 366 million in 2025 with 75 percent occurring in developing countries such as India and China In China economic prosperity and changes in diet and lifestyles have resulted in steep increase in prevalence of overweight obesity and diabetes Type 2 diabetes mellitus is associated with an increased risk for both micro-and macrovascular complications and cardiovascular diseases CVD are the most common causes of death in these patients Preventing the onset or the worsening of the cardiovascular diseases is thus one of the most important goals in managing type II diabetes This study is designed to better understand the incidence of cardiovascular events under current patterns of treatment in type 2 diabetic patients with either 3 or more risk factors for cardiovascular disease such as older age hypertension dyslipidemia etc or existing or prior history of coronary artery disease and stroke Approximately 1000 patients from major hospitals across several regions of China will be recruited for this study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CCDC | REGISTRY | CCMR | None |